The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending. But the Senate is expected to make major changes to the measure before it can go to President Donald Trump for his signature. This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico.
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.
Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.
The U.S. faces a crucial shortage of medical providers, especially in rural areas. The problem has been building for a while, experts say, but the pandemic accelerated it by pushing many doctors over the edge into early retirement or other fields.
A purge of FDA staff spared some people tasked with responding to a judge’s orders to disclose government records on covid vaccines, according to agency employees. The FOIA litigation was brought by Aaron Siri, an ally of Health and Human Services Secretary Robert F. Kennedy Jr.’s who represents anti-vaccine interests.
Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant applications, and they fear the Trump administration will abandon a promising field of medical research.
Republicans have proposed legislation in several states to ban the pioneering technology used in covid shots. Many doctors worry a huge medical advance could be rolled back.
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
By withdrawing from the World Health Organization and overhauling aid, Trump’s new executive orders endanger Americans and the globe, researchers warn. The move also cedes U.S. power to other nations.
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
